KO stock news · The Coca-Cola Company
Get alerts for KO
Follow The Coca-Cola Company (KO) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for KOCoca-Cola is changing how it runs its marketing around the world.
NeutralCoca-Cola is reorganizing its worldwide marketing team, but the report gives no expected business result. The change does not clearly alter the company's outlook.
Coca-Cola has picked new partners to help with its advertising.
NeutralCoca-Cola chose new agency partners to strengthen its marketing and brand reach. The story reports no results from their work, so this does not yet change how we read the company.
KFC is switching from Pepsi to Coca-Cola drinks after almost 40 years, making Coca-Cola stock popular.
Good for KOCoca-Cola won KFC’s U.S. drink business, adding a large restaurant chain and more brand visibility. Pepsi remains involved abroad, but the U.S. win favors Coca-Cola.
Coca-Cola surprises Pepsi by teaming up with KFC after almost 40 years together.
Good for KOCoca-Cola won KFC's U.S. drink business, giving it another large restaurant customer. The gain is positive, though it excludes KFC locations outside the U.S. and starts in 2027.
Defensive sectors like Health Care did better than others on Thursday, while Technology struggled.
NeutralCoca-Cola shares rose 1.19%, and the consumer staples group rose 1.50%. The report gives no company-specific business news, so this session does not change its outlook.
Rob Gronkowski turned down stock for his drink deal, but it ended up making him a lot of money.
NeutralCoca-Cola's past BodyArmor purchase is recalled through Rob Gronkowski's old stake payment. The story adds no current business results, so it does not change how we read Coca-Cola.
Trump's choice for Surgeon General has investments in tobacco and soda companies while Kennedy fights against sugary drinks and junk food.
NeutralCoca-Cola (KO): The nominee agreed to offload beverage stakes, including Coca-Cola, within 90 days if confirmed. One investor's planned sale does not change company fundamentals.